MRIGlobal’s Post

#ICYMI: When fighting infectious diseases, time is of the essence as they can spread rapidly after the incubation period. In this scenario molecular diagnostics are a gamechanger, enabling early detection and subsequent measures at disease control. Read the complete #IHFBlog, authored by Suraj Nair from the Deep Science Technology Investments Team at Ankur Capital, in which he gives us his insights on the role of #MolecularDiagnostics in our fight against #InfectiousDiseases. Read it here: https://lnkd.in/d-WcMfjn

#NewBlogAlert: #InfectiousDiseases tend to spread rapidly post a short incubation period. It thus becomes imperative to detect them early and put proper treatment and containment measures in place. In our latest #IHFBlog, Suraj Nair from the Deep Science Technology Investments Team at Ankur Capital, highlights the importance of #MolecularDiagnostics for early #diagnosis of infectious diseases and how it is changing the narrative. Read the full blog here: https://lnkd.in/d-WcMfjn #IndiaHealthFund #InfectiousDisease #MolecularDiagnostics #InfectiousDiseasePrevention

Could the blood of camel species help save us from serious diseases. DW documentary. Germany. 44 Minutes. Excerpt: Camel blood contains immunological superpowers. It all began in the 1990s with a discovery at the Free University of Brussels: students used dromedary blood in an experiment and came across previously unknown antibodies. The university scientists discovered these antibodies are present in all camel species. And, they have amazing properties. Small fragments can separate from the base of the antibody -- without causing any damage and while retaining their full binding capacity. This was the discovery of the nanobody: a tiny, extremely robust molecule which, due to its small size, can also penetrate areas too small to be targeted by complete antibodies. The nanobody, however, can attach itself with extremely high precision to pathogenic antigens. This discovery triggered a wave of innovations and impacted big pharmaceutical companies. In 2018, the first drug based on nanobodies went on the market, designed to combat an autoimmune blood clotting disorder. Numerous potential applications were developed within a very short space of time. Whether in the fight against cancer, in Alzheimer's diagnostics or to kill pathogenic bacteria - the success of camel antibodies has been so resounding that many medical research centers now have their own herds of llamas or alpacas.

Nonenveloped RNA virus belong to the family of Caliciviruses which causes severe diarrhoeal diseases and vomiting in humans and is considered the most common cause of virus-related gastroenteritis, particularly in the winter months. Find out more about our pathogen of the month here: https://lnkd.in/gzFq4YE5

🦠 Hepatitis C is a disease with a significant #global impact (HCV) ✍️ it is also known as 'the #silent dragon' and 'the disease of the #new millennium 🐲 👌Learn more about #Sofosbuvir use in #HCV: https://lnkd.in/dFQNQ6Ay

🦠Hepatitis C is a disease with a significant global impact (HCV) ✅ it is also known as 'the silent dragon' and 'the disease of the new millennium 🐲 👌Learn more about Sofosbuvir use in #HCV: https://lnkd.in/d9_s4Kyy

🦠Hepatitis C is a disease with a significant global impact (HCV) ✅ it is also known as 'the silent dragon' and 'the disease of the new millennium 🐲 👌Learn more about Sofosbuvir use in #HCV: https://lnkd.in/dFQNQ6Ay

The FDA announced yesterday that Zika Virus (ZIKV) is no longer classified as a Relevant Communicable Disease Agent or Disease (RCDAD), withdrawing its previous guidance on ZIKV donor screening. This decision is based on significant decreases in ZIKV cases, with no local transmissions in the U.S. since 2017 and no confirmed cases in U.S. territories since 2019. As a result, HCT/P establishments are no longer required to screen donors for ZIKV. Under this updated protocol, these establishments will be able to accept a greater number of eligible donors and will contribute to improved access to therapies for a more diverse patient population. Follow the link below for more details: #DonorScreening #CordBlood #DonorTesting #FDARegulation

World #Hepatitis Day is observed annually on July 28th to raise awareness about viral hepatitis, a group of infectious diseases that affect the liver. Hepatitis is a significant global health challenge. There are five main strains of the hepatitis virus – A, B, C, D, and E. Collectively, hepatitis B and C are the most prevalent infections, resulting in 1.3 million deaths and 2.2 million new infections annually. ⚠️These infections lead to serious and potentially fatal complications such as liver cirrhosis, liver failure and hepatocellular carcinoma if left untreated. Symptoms include fatigue, loss of appetite, abdominal pain, jaundice and dark urine, but many infected individuals may be asymptomatic, especially in the early stages.⏰ Early diagnosis✅ through proper testing is crucial, as it allows for timely #treatment and management to prevent long-term liver damage and other adverse health outcomes. Hepatitis testing typically involves blood tests to detect the presence of viral antibodies or viral genetic material. Hangzhou AllTest Biotech Co.,Ltd., a leading provider of medical diagnostic solutions, is committed to supporting the global effort to eliminate viral hepatitis. The company's range of reliable and affordable hepatitis screening tests aim to improve access to essential diagnostics and facilitate early detection, a key step in the fight against this public health challenge.💪🛡️ #WorldHepatitisDay #ViralHepatitis #LiverHealth #InfectiousDiseases #HepatitisB #EarlyDetection #MedicalDiagnosis #Healthcare #GlobalHealth #AllTest #Awareness